Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States of America.
Department of Gastroenterology and Hepatology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.
PLoS One. 2020 Feb 12;15(2):e0228874. doi: 10.1371/journal.pone.0228874. eCollection 2020.
Matriptase plays important roles in epithelial integrity and function, which depend on its sorting to the basolateral surface of cells, where matriptase zymogen is converted to an active enzyme in order to act on its substrates. After activation, matriptase undergoes HAI-1-mediated inhibition, internalization, transcytosis, and secretion from the apical surface into the lumen. Matriptase is a mosaic protein with several distinct protein domains and motifs, which are a reflection of matriptase's complex cellular itinerary, life cycle, and the tight control of its enzymatic activity. While the molecular determinants for various matriptase regulatory events have been identified, the motif(s) required for translocation of human matriptase to the basolateral plasma membrane is unknown. The motif previously identified in rat matriptase is not conserved between the rodent and the primate. We, here, revisit the question for human matriptase through the use of a fusion protein containing a green fluorescent protein linked to the matriptase N-terminal fragment ending at Gly-149. A conserved seven amino acid motif EEGEVFL, which is similar to the monoleucine C-terminal to an acidic cluster motif involved in the basolateral targeting for some growth factors, has been shown to be required for matriptase translocation to the basolateral plasma membrane of polarized MDCK cells. Furthermore, time-lapse video microscopy showed that the motif appears to be required for entry into the correct transport vesicles, by which matriptase can undergo rapid trafficking and translocate to the plasma membrane. Our study reveals that the EEGEVFL motif is necessary, but may not be sufficient, for matriptase basolateral membrane targeting and serves as the basis for further research on its pathophysiological roles.
组织蛋白酶 G 酶原激活物在维持上皮组织完整性和功能中发挥着重要作用,其功能的发挥依赖于该酶原的正确分拣至细胞的基底外侧表面,在该处酶原被激活为有活性的蛋白酶,进而作用于其底物。酶原激活后,经 HAI-1 介导的抑制、内化、跨细胞转运及从顶端膜表面分泌至腔中,完成其分泌途径。组织蛋白酶 G 酶原激活物是一种镶嵌蛋白,具有几个不同的蛋白结构域和基序,这反映了该酶原复杂的细胞内行程、生命周期以及其酶活性的严格调控。虽然已经确定了各种组织蛋白酶 G 酶原激活调节事件的分子决定因素,但人组织蛋白酶 G 酶原向基底外侧质膜易位所需的基序尚不清楚。在啮齿动物和灵长类动物之间,先前在大鼠组织蛋白酶 G 酶原中鉴定出的基序并不保守。在此,我们通过使用一种融合蛋白来重新研究人组织蛋白酶 G 酶原的问题,该融合蛋白包含一个与甘氨酸 149 末端的组织蛋白酶 G 酶原 N 端片段相连的绿色荧光蛋白。一个保守的七氨基酸基序 EEGEVFL 与酸性簇基序后单亮氨酸基序相似,该基序参与了一些生长因子的基底外侧靶向,已被证明对于组织蛋白酶 G 酶原向极化的 MDCK 细胞的基底外侧质膜的易位是必需的。此外,延时视频显微镜显示,该基序似乎对于进入正确的转运小泡是必需的,通过该小泡,组织蛋白酶 G 酶原可以快速转运并易位至质膜。我们的研究表明,EEGEVFL 基序对于组织蛋白酶 G 酶原的基底外侧膜靶向是必需的,但可能不是充分的,它为进一步研究其生理病理作用奠定了基础。